Cargando…
Correction to: Recombinant human interleukin-7 reverses T cell exhaustion ex vivo in critically ill COVID-19 patients
Autores principales: | Bidar, Frank, Hamada, Sarah, Gossez, Morgane, Coudereau, Remy, Lopez, Jonathan, Cazalis, Marie-Angelique, Tardiveau, Claire, Brengel-Pesce, Karen, Mommert, Marine, Buisson, Marielle, Conti, Filippo, Rimmelé, Thomas, Lukaszewicz, Anne-Claire, Argaud, Laurent, Cour, Martin, Monneret, Guillaume, Venet, Fabienne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972669/ https://www.ncbi.nlm.nih.gov/pubmed/35362873 http://dx.doi.org/10.1186/s13613-022-01007-7 |
Ejemplares similares
-
Recombinant human interleukin-7 reverses T cell exhaustion ex vivo in critically ill COVID-19 patients
por: Bidar, Frank, et al.
Publicado: (2022) -
T cell response against SARS-CoV-2 persists after one year in patients surviving severe COVID-19
por: Venet, Fabienne, et al.
Publicado: (2022) -
Monitoring NLRP3 Inflammasome Activation and Exhaustion in Clinical Samples: A Refined Flow Cytometry Protocol for ASC Speck Formation Measurement Directly in Whole Blood after Ex Vivo Stimulation
por: Coudereau, Rémy, et al.
Publicado: (2022) -
Seroconversion in septic ICU patients presenting with COVID-19: necessary but not sufficient
por: Conti, Filippo, et al.
Publicado: (2021) -
Characterization of Circulating IL-10-Producing Cells in Septic Shock Patients: A Proof of Concept Study
por: Fabri, Astrid, et al.
Publicado: (2021)